AbbVie's HUMIRA® (Adalimumab) Approved by Health Canada to Treat Pediatric Patients with Chronic Non-infectious Anterior Uveitis
Morning Star,
Canada NewsWire MONTREAL, Feb. 20, 2019 The approval marks HUMIRA as the only approved biologic treatment option in Canada for…